Cargando…
Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure
Background: In patients with heart failure (HF), discontinued medical therapy because of adverse events (AE) is associated with high mortality. Patients with type 2 diabetes mellitus (T2DM) treated with sodium-glucose co-transporter 2 inhibitors (SGLT2i) have a lower risk of HF, but AE sometimes occ...
Autores principales: | Yazaki, Mayu, Nabeta, Takeru, Inomata, Takayuki, Maemura, Kenji, Ooki, Takumi, Fujita, Teppei, Iida, Yuichiro, Ikeda, Yuki, Ishii, Shunsuke, Naruke, Takashi, Ako, Junya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929704/ https://www.ncbi.nlm.nih.gov/pubmed/33693174 http://dx.doi.org/10.1253/circrep.CR-19-0080 |
Ejemplares similares
-
Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020) -
Clinical significance of left atrial geometry in dilated cardiomyopathy patients: A cardiovascular magnetic resonance study
por: Yazaki, Mayu, et al.
Publicado: (2020) -
Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis
por: Nabeta, Takeru, et al.
Publicado: (2021) -
Native T1 high region and left ventricular ejection fraction recovery in patients with dilated cardiomyopathy
por: Yazaki, Mayu, et al.
Publicado: (2023) -
Association between intestinal oedema and oral loop diuretic resistance in hospitalized patients with acute heart failure
por: Ikeda, Yuki, et al.
Publicado: (2021)